|
US3201389A
(en)
|
1962-09-24 |
1965-08-17 |
Kyowa Hakko Kogyo Kk |
Method for preparing ribonucleoside-5'-phosphates or their salts from ribonucleosides
|
|
US3451997A
(en)
|
1965-11-30 |
1969-06-24 |
Kyowa Hakko Kogyo Kk |
Monothio-phosphate ester catalysis for preparation of ribonucleoside derivatives
|
|
US4172896A
(en)
|
1978-06-05 |
1979-10-30 |
Dainippon Pharmaceutical Co., Ltd. |
Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
|
|
US4411995A
(en)
|
1981-09-28 |
1983-10-25 |
Massachusetts Institute Of Technology |
Synthesis of nicotinamide cofactors
|
|
GB9217295D0
(en)
|
1992-08-14 |
1992-09-30 |
Wellcome Found |
Controlled released tablets
|
|
US5358970A
(en)
|
1993-08-12 |
1994-10-25 |
Burroughs Wellcome Co. |
Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
|
|
GB9315856D0
(en)
|
1993-07-30 |
1993-09-15 |
Wellcome Found |
Stabilized pharmaceutical
|
|
US5541231A
(en)
|
1993-07-30 |
1996-07-30 |
Glaxo Wellcome Inc. |
Stabilized Pharmaceutical
|
|
ATE391492T1
(de)
|
1997-07-29 |
2008-04-15 |
Alcon Lab Inc |
Ophthalmische zusammensetzungen enthaltend galaktomannanpolymere und borat
|
|
EP1051167A1
(en)
|
1998-01-29 |
2000-11-15 |
Sepracor, Inc. |
Pharmaceutical uses of optically pure (-) -bupropion
|
|
US8889112B2
(en)
|
1999-09-16 |
2014-11-18 |
Ocularis Pharma, Llc |
Ophthalmic formulations including selective alpha 1 antagonists
|
|
RS51031B
(sr)
|
2001-04-30 |
2010-10-31 |
Trommsdorff Gmbh & Co.Kg.Arzneimittel |
Farmaceutski aktivni estri uridina
|
|
US7977049B2
(en)
|
2002-08-09 |
2011-07-12 |
President And Fellows Of Harvard College |
Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
|
|
US20040224039A1
(en)
|
2003-02-12 |
2004-11-11 |
Donald Brucker |
Compositions and methods for the treatment of diseases and disorder associated with oxidative damage
|
|
US6887855B2
(en)
*
|
2003-03-17 |
2005-05-03 |
Pharmion Corporation |
Forms of 5-azacytidine
|
|
US6933289B2
(en)
|
2003-07-01 |
2005-08-23 |
Allergan, Inc. |
Inhibition of irritating side effects associated with use of a topical ophthalmic medication
|
|
ES2593113T3
(es)
|
2003-08-07 |
2016-12-05 |
Allergan, Inc. |
Composiciones para el suministro de agentes terapéuticos en los ojos y métodos para obtener y usar los mismos
|
|
US20050059744A1
(en)
|
2003-09-12 |
2005-03-17 |
Allergan, Inc. |
Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
|
|
EP1727546A4
(en)
|
2003-10-31 |
2008-07-09 |
Robarts Res Inst |
METHOD AND FORMULATIONS FOR THE PROTECTION OF CELLS AND FOR THE TREATMENT OF ILLNESSES AND SUFFERING THROUGH OPTIMIZATION OF INTRA-CELLULAR NAD CONCENTRATION
|
|
PT1755391E
(pt)
|
2004-06-04 |
2016-02-03 |
Univ Washington |
Métodos e composições para o tratamento de neuropatias
|
|
AU2006218403A1
(en)
|
2005-03-03 |
2006-09-08 |
Sirtris Pharmaceuticals, Inc. |
Fused heterocyclic compounds and their use as sirtuin modulators
|
|
US20070149466A1
(en)
|
2005-07-07 |
2007-06-28 |
Michael Milburn |
Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
|
|
US7855289B2
(en)
|
2005-08-04 |
2010-12-21 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin modulating compounds
|
|
JP5063878B2
(ja)
|
2005-08-30 |
2012-10-31 |
扶桑薬品工業株式会社 |
硫化水素塩を含有する消化器系疾患の予防／治療用組成物
|
|
US20080020413A1
(en)
*
|
2006-03-29 |
2008-01-24 |
Columbia University |
Crystalline visfatin and methods therefor
|
|
CA2646674A1
(en)
|
2006-04-20 |
2007-11-01 |
Fred Hutchinson Cancer Research Center |
Use of chalcogenides for treating shock and other adverse conditions
|
|
US20080318892A1
(en)
|
2006-04-28 |
2008-12-25 |
John Geoffrey Pickering |
Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of nad
|
|
WO2007136744A1
(en)
*
|
2006-05-19 |
2007-11-29 |
The Johns Hopkins University |
Crystal structure of a substrate complex of nampt/pbef/visfatin
|
|
EP2124985A4
(en)
*
|
2007-01-26 |
2011-06-08 |
Univ Washington |
METHOD AND COMPOSITIONS FOR TREATING NERVOUS ELEMENTS
|
|
CN101497638B
(zh)
|
2008-01-30 |
2012-09-26 |
中国科学院大连化学物理研究所 |
一种nad+类似物及其合成和应用
|
|
US11219696B2
(en)
|
2008-12-19 |
2022-01-11 |
Nationwide Children's Hospital |
Delivery of polynucleotides using recombinant AAV9
|
|
CN101601679B
(zh)
|
2009-03-17 |
2011-08-10 |
中国人民解放军第二军医大学 |
一种烟酰胺单核苷酸的应用
|
|
US20100297079A1
(en)
|
2009-05-20 |
2010-11-25 |
Chimerix, Inc. |
Compounds, compositions and methods for treating viral infection
|
|
KR20110061909A
(ko)
*
|
2009-12-02 |
2011-06-10 |
삼성전자주식회사 |
도펀트로 도핑된 그라펜 및 이를 이용한 소자
|
|
WO2011130595A2
(en)
|
2010-04-15 |
2011-10-20 |
Sirtris Pharmaceuticals, Inc. |
Sirtuin activators and activation assays
|
|
US8481711B2
(en)
|
2010-07-06 |
2013-07-09 |
Hidenori Kamanishi |
Neurite outgrowth agent
|
|
WO2012031196A1
(en)
|
2010-09-03 |
2012-03-08 |
Forma Therapeutics, Inc. |
4- { [ ( pyridin- 3 - yl -methyl) aminocarbonyl] amino} benzene - sulfone derivatives as nampt inhibitors for therapy of diseases such as cancer
|
|
US9676721B2
(en)
|
2010-09-03 |
2017-06-13 |
Forma Tm, Llc |
Compounds and compositions for the inhibition of NAMPT
|
|
AU2011295725B2
(en)
|
2010-09-03 |
2015-03-26 |
Forma Tm, Llc. |
Novel compounds and compositions for the inhibition of NAMPT
|
|
WO2012094343A1
(en)
|
2011-01-05 |
2012-07-12 |
Trilink Biotechnologies |
Chemically substituted thermosensitive probes and cofactors for hot start ligation
|
|
US20140065099A1
(en)
|
2011-02-15 |
2014-03-06 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Methods of Treating Mitochondrial Dysfunction
|
|
US20120107888A1
(en)
|
2011-02-17 |
2012-05-03 |
Qteros, Inc. |
Modulation of fermentation products through vitamin supplementation
|
|
AR082888A1
(es)
|
2011-05-04 |
2013-01-16 |
Forma Therapeutics Inc |
Compuestos de piridina para la inhibicion de nampt
|
|
US20120328526A1
(en)
|
2011-06-27 |
2012-12-27 |
University Of Maryland, Baltimore |
Modulation of Nad+ Activity in Neuropathophysiological Conditions and Uses Thereof
|
|
EP3345901A3
(en)
|
2011-06-29 |
2018-09-12 |
President and Fellows of Harvard College |
Small molecules as antiaging agents
|
|
ES2620612T3
(es)
|
2012-03-02 |
2017-06-29 |
Genentech, Inc. |
Derivados de sulfóxidos y sulfonas de piridinilo y pirimidinilo
|
|
ES2620668T3
(es)
|
2012-03-02 |
2017-06-29 |
Genentech, Inc. |
Derivados de amidas y sulfonamidas amido espirocíclicas
|
|
US10696692B2
(en)
|
2012-03-02 |
2020-06-30 |
Forma Tm, Llc |
Amido-benzyl sulfone and sulfoxide derivates
|
|
WO2013127268A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech,Inc. |
Amido-benzyl sulfone and sulfonamide derivatives
|
|
WO2013130943A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Alkyl-and di-substituted amido-benzyl sulfonamide derivatives
|
|
JP6289460B2
(ja)
|
2012-07-16 |
2018-03-07 |
コーネル ユニヴァーシティー |
難聴を治療するためのニコチンアミドリボシド
|
|
US9877981B2
(en)
*
|
2012-10-09 |
2018-01-30 |
President And Fellows Of Harvard College |
NAD biosynthesis and precursors for the treatment and prevention of cancer and proliferation
|
|
CN102876759A
(zh)
*
|
2012-10-29 |
2013-01-16 |
尚科生物医药（上海）有限公司 |
尼克酰胺腺嘌呤二核苷酸的制备方法
|
|
WO2014074715A1
(en)
|
2012-11-07 |
2014-05-15 |
Genentech, Inc. |
Cyclopropyl amide derivatives
|
|
WO2014111906A1
(en)
|
2013-01-21 |
2014-07-24 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Bioluminescence imaging of small biomolecules
|
|
EP2968306B1
(en)
|
2013-03-15 |
2023-06-07 |
Washington University |
Administration of nicotinamide mononucleotide in the treatment of dry eye
|
|
US20140271355A1
(en)
|
2013-03-15 |
2014-09-18 |
Sabre Intellectual Property Holdings Llc |
Apparatus and process for focused gas phase application of biocide
|
|
GB201313465D0
(en)
|
2013-07-29 |
2013-09-11 |
Queens University Of The Belfast |
Methods of preparing nicotinamide riboside and derivatives thereof
|
|
US20160287621A1
(en)
|
2013-11-06 |
2016-10-06 |
President And Fellows Of Harvard College |
Biological production of nad precursors and analogs
|
|
AU2014348672A1
(en)
|
2013-11-12 |
2016-06-02 |
Ortho-Nutra, Llc |
Theacrine-based supplement and method of use thereof
|
|
US10398701B2
(en)
|
2013-11-12 |
2019-09-03 |
Ortho-Nutra, Llc |
Theacrine-based supplement and method of use thereof in a synergistic combination with caffeine
|
|
US20160279161A1
(en)
|
2013-11-14 |
2016-09-29 |
Newsouth Innovation Pty Limited |
Senescence and senescence associated secretory phenotype
|
|
CN104367587B
(zh)
|
2013-12-06 |
2018-06-29 |
中国人民解放军第二军医大学 |
烟酰胺单核苷酸在制备促脑缺血后神经再生药物中的应用
|
|
US20150258052A1
(en)
|
2014-03-13 |
2015-09-17 |
Salk Institute For Biological Studies |
Methods of using fexaramine and agents that increase sympathetic nervous system activity to promote browning of white adipose tissue
|
|
JP2017511304A
(ja)
|
2014-03-13 |
2017-04-20 |
ソーク インスティチュート フォー バイオロジカル スタディーズ |
フェキサラミン類似体ならびに作製方法および使用方法
|
|
US10301268B2
(en)
|
2014-03-13 |
2019-05-28 |
The Salk Institute For Biological Studies |
Analogs of fexaramine and methods of making and using
|
|
WO2015186068A1
(en)
|
2014-06-02 |
2015-12-10 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Preparation and use of crystalline beta-d-nicotinamide riboside
|
|
WO2015187649A1
(en)
|
2014-06-03 |
2015-12-10 |
Sulfagenix, Inc. |
Methods and compositions for treating nitric oxide deficiency disorders and related conditions
|
|
RU2016149767A
(ru)
|
2014-06-06 |
2018-07-16 |
Глэксосмитклайн Интеллекчуал Проперти (Но.2) Лимитед |
Аналоги никотинамидрибозида и фармацевтические композиции и их применение
|
|
CN106715454B
(zh)
|
2014-07-24 |
2020-06-16 |
格雷斯公司 |
烟酰胺核苷的结晶形式
|
|
US10653782B2
(en)
|
2014-11-25 |
2020-05-19 |
Nortwestern University |
Retroviral particles expressing Sirt1 embedded within PPCN
|
|
AU2015362283B2
(en)
|
2014-12-09 |
2020-07-30 |
Amorepacific Corporation |
Composition for activating longevity gene
|
|
CA2978069C
(en)
|
2015-03-09 |
2021-10-12 |
W.R. Grace & Co.-Conn. |
Crystalline form of nicotinamide riboside
|
|
CN104817604B
(zh)
|
2015-03-16 |
2017-08-04 |
邦泰生物工程(深圳)有限公司 |
一种β‑烟酰胺单核苷酸的纯化方法
|
|
US20180051253A1
(en)
|
2015-03-18 |
2018-02-22 |
The Regents Of The University Of California |
Methods of preventing and reversing stem cell aging
|
|
CA2987986A1
(en)
|
2015-06-04 |
2016-12-08 |
Chromadex, Inc. |
Selective solvent free phosphorylation
|
|
US20180177703A1
(en)
|
2015-06-25 |
2018-06-28 |
N.V. Perricone Llc |
Niacinamide Mononucleotide Formulations For Skin Aging
|
|
AU2016302005B2
(en)
|
2015-08-05 |
2021-03-04 |
Metro International Biotech, Llc |
Nicotinamide mononucleotide derivatives and their uses
|
|
TW201713774A
(zh)
|
2015-08-06 |
2017-04-16 |
Kohjin Life Sciences Co Ltd |
含有β-菸鹼醯胺單核苷酸的酵母萃取物及其製造方法
|
|
GB2542881B
(en)
|
2015-10-02 |
2020-01-01 |
Carr Andrew |
Crystal forms of ß-nicotinamide mononucleotide
|
|
KR20180063179A
(ko)
|
2015-10-07 |
2018-06-11 |
조엘 후이젠가 |
인간의 노화에 따른 노쇠의 방어 및 회복을 위한 생체 경로의 복구
|
|
WO2017079195A1
(en)
|
2015-11-02 |
2017-05-11 |
Mitobridge, Inc. |
Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseases
|
|
US10654882B2
(en)
|
2015-12-21 |
2020-05-19 |
Showa Denko K.K. |
Nicotinamide mononucleotide derivative and salt thereof, method for producing same, topical skin preparation, cosmetic and food additive
|
|
EP3187180A1
(en)
|
2015-12-28 |
2017-07-05 |
Ludwig-Maximilians-Universität München |
Adenosylhomocysteinase binding substances for medical use
|
|
WO2017145151A1
(en)
|
2016-02-23 |
2017-08-31 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Process for preparation of nicotinamide riboside (nr) and cosmetic composition comprising (nr and a phosphate-binding agent
|
|
US10000520B2
(en)
|
2016-03-16 |
2018-06-19 |
ChromaDex Inc. |
B-vitamin and amino acid conjugates ofnicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof
|
|
MX393076B
(es)
|
2016-04-20 |
2025-03-24 |
Chromadex Inc |
Uso de derivados de ribósido de ácido nicotínico o ribósido de nicotinamida, y derivados reducidos de estos, como precursores que incrementan nad+
|
|
WO2017218580A1
(en)
|
2016-06-14 |
2017-12-21 |
Rejuvenation Therapeutics Corporation |
Synthetic methods for the preparation of nicotinamide riboside and related compounds
|
|
WO2018023207A1
(zh)
|
2016-07-30 |
2018-02-08 |
邦泰生物工程(深圳)有限公司 |
一种制备烟酰胺单核苷酸的方法
|
|
WO2018023208A1
(zh)
|
2016-07-30 |
2018-02-08 |
邦泰生物工程(深圳)有限公司 |
一种制备烟酰胺单核苷酸的方法
|
|
CN108026130B
(zh)
|
2016-07-30 |
2021-04-02 |
邦泰生物工程(深圳)有限公司 |
一种制备烟酰胺单核苷酸的方法
|
|
WO2018023205A1
(zh)
|
2016-07-30 |
2018-02-08 |
邦泰生物工程(深圳)有限公司 |
一种烟酰胺单核苷酸的纯化方法
|
|
WO2018023209A1
(zh)
|
2016-07-30 |
2018-02-08 |
邦泰生物工程(深圳)有限公司 |
一种制备烟酰胺单核苷酸的方法
|
|
WO2018023210A1
(zh)
|
2016-07-30 |
2018-02-08 |
邦泰生物工程(深圳)有限公司 |
一种制备烟酰胺单核苷酸的方法
|
|
WO2018047715A1
(ja)
*
|
2016-09-06 |
2018-03-15 |
協和発酵バイオ株式会社 |
β－ニコチンアミドモノヌクレオチドの結晶及びその製造方法
|
|
EP3512158B1
(en)
|
2016-09-09 |
2021-08-18 |
Nec Corporation |
Transmitting device, receiving device, quantum key distribution method, and quantum key distribution program for quantum key distribution system
|
|
ES2955713T3
(es)
|
2016-09-13 |
2023-12-05 |
Megumi Tanaka |
Agente de mejora de la función visual, y método para mejorar la función visual
|
|
US20200009170A1
(en)
|
2016-09-13 |
2020-01-09 |
Megumi Tanaka |
Sleep display agent property and method for improving sleep disorders
|
|
EP3538099A4
(en)
|
2016-11-11 |
2020-06-17 |
The Queen's University of Belfast |
EFFICIENT AND SCALABLE SYNTHESIS OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS OF THEM, ADENYLYDINUCLEOTIDE CONJUGATES THEREOF AND NEW-WAY CRYSTALS
|
|
US20190328761A1
(en)
|
2016-12-21 |
2019-10-31 |
Newsouth Innovations Pty Limited |
Methods for enhancing vascular density
|
|
CN106755209B
(zh)
|
2016-12-29 |
2021-07-23 |
苏州汉酶生物技术有限公司 |
一种酶法制备β-烟酰胺单核苷酸的方法
|
|
WO2018132833A1
(en)
|
2017-01-13 |
2018-07-19 |
The Regents Of The University Of Colorado, A Body Corporate |
Methods for treating hypertension and arterial stiffness
|
|
KR102520690B1
(ko)
|
2017-01-31 |
2023-04-10 |
오리엔탈고우보고오교가부시끼가이샤 |
다분화능성 줄기세포 증식 촉진제
|
|
JP6920071B2
(ja)
|
2017-02-16 |
2021-08-18 |
ワシントン・ユニバーシティＷａｓｈｉｎｇｔｏｎ Ｕｎｉｖｅｒｓｉｔｙ |
アディポネクチン分泌向上剤
|
|
JP7182289B2
(ja)
|
2017-04-05 |
2022-12-02 |
コーネル ユニヴァーシティー |
β－ニコチネートエステルヌクレオチドおよびその調製プロセス
|
|
CA3071561A1
(en)
|
2017-07-31 |
2019-02-07 |
Newsouth Innovations Pty Limited |
Methods for increasing fertility
|
|
WO2019152416A1
(en)
|
2018-01-30 |
2019-08-08 |
Metro International Biotech, Llc |
Nicotinamide riboside analogs, pharmaceutical compositions, and uses thereof
|
|
US20210388018A1
(en)
|
2018-10-01 |
2021-12-16 |
Cornell University |
Methyl and ethyl nicotinate-riboside-5-phosphates, preparation thereof and methods of use thereof
|
|
KR20210108400A
(ko)
|
2018-12-10 |
2021-09-02 |
크로마덱스 아이엔씨. |
니코티노일 리보사이드 및 이의 유도체의 결정질 형태 및 이의 제조 방법
|
|
US11939348B2
(en)
|
2019-03-22 |
2024-03-26 |
Metro International Biotech, Llc |
Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide
|
|
WO2020197882A1
(en)
|
2019-03-22 |
2020-10-01 |
Metro International Biotech, Llc |
Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide
|
|
US10618927B1
(en)
|
2019-03-22 |
2020-04-14 |
Metro International Biotech, Llc |
Compositions and methods for modulation of nicotinamide adenine dinucleotide
|
|
EP4153323A1
(fr)
|
2020-05-20 |
2023-03-29 |
Nuvamid SA |
Compositions cosmetiques anti-age comprenant du nmn
|
|
IL308577A
(en)
|
2021-05-27 |
2024-01-01 |
Metro Int Biotech Llc |
Crystalline solids of nicotinic acid mononucleotides and their esters and methods for their preparation and use
|